|
ZNF644 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.969210E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.235780E-01 |
| Normal-vs-Stage2 |
7.771800E-01 |
| Normal-vs-Stage3 |
6.696200E-01 |
| Normal-vs-Stage4 |
3.450800E-01 |
| Stage1-vs-Stage2 |
3.942400E-01 |
| Stage1-vs-Stage3 |
3.394200E-01 |
| Stage1-vs-Stage4 |
1.283010E-01 |
| Stage2-vs-Stage3 |
9.731000E-01 |
| Stage2-vs-Stage4 |
2.812000E-01 |
| Stage3-vs-Stage4 |
1.831220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.309350E-01 |
| Normal-vs-AfricanAmerican |
4.673600E-01 |
| Normal-vs-Asian |
9.887400E-01 |
| Caucasian-vs-AfricanAmerican |
5.762200E-01 |
| Caucasian-vs-Asian |
6.001000E-01 |
| AfricanAmerican-vs-Asian |
7.710000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.231800E-02 |
| Normal-vs-Female |
8.355400E-01 |
| Male-vs-Female |
4.361800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.678000E-01 |
| Normal-vs-Extreme_Weight |
6.901800E-02 |
| Normal-vs-Obese |
4.810400E-01 |
| Normal-vs-Extreme_Obese |
3.567200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.337600E-01 |
| Normal_Weight-vs-Obese |
9.985000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.638600E-01 |
| Extreme_Weight-vs-Obese |
2.002600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.764800E-01 |
| Obese-vs-Extreme_Obese |
7.141600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.020200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.938400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.476400E-02 |
| Normal-vs-Age(81-100Yrs) |
1.613740E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.530200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.482000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.758000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.031780E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.653800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.840800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.650000E-01 |
| Normal-VS-Type2 PRCC |
1.129670E-02 |
| Normal-VS-KIRP CIMP |
3.916800E-01 |
| Normal-VS-Unclassified PRCC |
9.915400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.116400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.364370E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.929600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.770000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.656200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.512600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.015760E-02 |
| Normal-vs-N1 |
1.115610E-01 |
| Normal-vs-N2 |
3.322000E-01 |
| N0-vs-N1 |
2.616400E-03 |
| N0-vs-N2 |
8.507600E-01 |
| N1-vs-N2 |
2.133000E-01 |
|
|
